Back to trial details

Intake questionnaire

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Applying to Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 70 years old?
2. Have you been diagnosed with SLE (Systemic Lupus)?
3. Are you able to travel to Chicago for study visits?